Cargando…
Experimental medication treatment approaches for depression
Depression is one of the most common psychiatric conditions. Symptoms can lead to significant disability, which result in impairments in overall quality of life. Though there are many approved antidepressant treatments for depression—including selective serotonin reuptake inhibitors, tricyclic antid...
Autores principales: | Ionescu, D F, Papakostas, G I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5416676/ https://www.ncbi.nlm.nih.gov/pubmed/28323287 http://dx.doi.org/10.1038/tp.2017.33 |
Ejemplares similares
-
Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder
por: Papakostas, George I., et al.
Publicado: (2008) -
Pharmacological approaches to the challenge of treatment-resistant depression
por: Ionescu, Dawn F., et al.
Publicado: (2015) -
Experimental Therapeutics in Treatment-Resistant Major Depressive Disorder
por: Kaur, Mandeep, et al.
Publicado: (2021) -
Novel Pharmacological Approaches to the Treatment of Depression
por: Elias, Elias, et al.
Publicado: (2022) -
Modulation of the Serotonergic Receptosome in the Treatment of Anxiety and Depression: A Narrative Review of the Experimental Evidence
por: Villas-Boas, Gustavo R., et al.
Publicado: (2021)